1. Home
  2. BZUN vs SABS Comparison

BZUN vs SABS Comparison

Compare BZUN & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.69

Market Cap

176.9M

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.99

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
SABS
Founded
2007
2014
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.9M
181.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BZUN
SABS
Price
$2.69
$3.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.00
AVG Volume (30 Days)
201.3K
253.6K
Earning Date
11-25-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,372,022,139.00
$114,698.00
Revenue This Year
$5.92
N/A
Revenue Next Year
$3.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.08
N/A
52 Week Low
$2.12
$1.00
52 Week High
$4.88
$6.60

Technical Indicators

Market Signals
Indicator
BZUN
SABS
Relative Strength Index (RSI) 35.45 59.35
Support Level $2.73 $3.54
Resistance Level $2.87 $4.08
Average True Range (ATR) 0.15 0.30
MACD 0.01 -0.04
Stochastic Oscillator 23.96 75.28

Price Performance

Historical Comparison
BZUN
SABS

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: